These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 3301083)
1. Effects of captopril on peripheral hemodynamics in severe congestive heart failure. Nishimura H; Kubo S; Ueyama M; Kubota J; Kawamura K Clin Exp Hypertens A; 1987; 9(2-3):587-91. PubMed ID: 3301083 [TBL] [Abstract][Full Text] [Related]
2. Peripheral hemodynamic effects of captopril in patients with congestive heart failure. Nishimura H; Kubo S; Ueyama M; Kubota J; Kawamura K Am Heart J; 1989 Jan; 117(1):100-5. PubMed ID: 2643280 [TBL] [Abstract][Full Text] [Related]
3. Peripheral haemodynamic effects of inhibition of prostaglandin synthesis in congestive heart failure and interactions with captopril. Townend JN; Doran J; Lote CJ; Davies MK Br Heart J; 1995 May; 73(5):434-41. PubMed ID: 7786658 [TBL] [Abstract][Full Text] [Related]
4. Effects of captopril on forearm oxygen consumption during dynamic handgrip exercise in patients with congestive heart failure. Imaizumi T; Takeshita A; Nakamura N; Sakai K; Hirooka Y; Suzuki S; Yoshida M; Nakamura M Jpn Heart J; 1990 Nov; 31(6):817-28. PubMed ID: 2084278 [TBL] [Abstract][Full Text] [Related]
5. Hemodynamic and regional blood flow response to captopril in congestive heart failure. Levine TB; Olivari MT; Cohn JN Am J Med; 1984 May; 76(5B):38-42. PubMed ID: 6375361 [TBL] [Abstract][Full Text] [Related]
6. The contribution of the renin-angiotensin system to limb vasoregulation in patients with heart failure: observations during orthostasis and alpha-adrenergic blockade. Creager MA; Faxon DP; Rockwell SM; Gavras H; Coffman JD Clin Sci (Lond); 1985 Jun; 68(6):659-67. PubMed ID: 2485267 [TBL] [Abstract][Full Text] [Related]
7. Forearm venous distensibility in relation to severity of symptoms and hemodynamic data in patients with congestive heart failure. Ikenouchi H; Iizuka M; Sato H; Momomura S; Serizawa T; Sugimoto T Jpn Heart J; 1991 Jan; 32(1):17-34. PubMed ID: 2038122 [TBL] [Abstract][Full Text] [Related]
8. Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure. Faxon DP; Creager MA; Halperin JL; Bernard DB; Ryan TJ Am J Med; 1984 May; 76(5B):104-10. PubMed ID: 6203405 [TBL] [Abstract][Full Text] [Related]
9. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. van Wijngaarden J; Smit AJ; de Graeff PA; van Gilst WH; van der Broek SA; van Veldhuisen DJ; Lie KI; Wesseling H J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753 [TBL] [Abstract][Full Text] [Related]
10. Captopril improves hemodynamic response to static exercise in patients with congestive heart failure: a double-blind, placebo-controlled, randomized trial. Borgi C; Magelli C; Costa FV; Magnani B; Ambrosioni E Clin Cardiol; 1990 May; 13(5):329-34. PubMed ID: 2189613 [TBL] [Abstract][Full Text] [Related]
12. Effect of captopril and enalapril on endothelial function in hypertensive patients. Creager MA; Roddy MA Hypertension; 1994 Oct; 24(4):499-505. PubMed ID: 8088918 [TBL] [Abstract][Full Text] [Related]
13. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function. Roberts DH; Tsao Y; Grimmer SF; Winstanley PA; Orme ML; Breckenridge AM Br J Clin Pharmacol; 1987 Aug; 24(2):163-72. PubMed ID: 2887190 [TBL] [Abstract][Full Text] [Related]
14. Quantitative differences in the hemodynamic effects of captopril and nitroprusside in severe chronic heart failure. Packer M; Meller J; Medina N; Yushak M Am J Cardiol; 1983 Jan; 51(1):183-8. PubMed ID: 6336876 [TBL] [Abstract][Full Text] [Related]
15. Effects of converting-enzyme inhibition on cardiorenal hemodynamics in patients with chronic congestive heart failure. Kubo S; Nishioka A; Nishimura H; Kawamura K; Takatsu T J Cardiovasc Pharmacol; 1985; 7(4):753-9. PubMed ID: 2410718 [TBL] [Abstract][Full Text] [Related]
16. A clinical study on the role of the renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure. Nishioka A; Kubo S; Hirota Y; Kawamura K; Takatsu T Jpn Heart J; 1982 Jul; 23(4):527-44. PubMed ID: 6752473 [TBL] [Abstract][Full Text] [Related]
17. Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors. Katz SD; Schwarz M; Yuen J; LeJemtel TH Circulation; 1993 Jul; 88(1):55-61. PubMed ID: 8391403 [TBL] [Abstract][Full Text] [Related]
18. The effects of sublingually administered nitroglycerin on forearm vascular resistance in patients with heart failure and in normal subjects. Imaizumi T; Takeshita A; Ashihara T; Nakamura M Circulation; 1985 Oct; 72(4):747-52. PubMed ID: 3928194 [TBL] [Abstract][Full Text] [Related]
19. Effect of captopril on glucose concentration. Possible role of augmented postprandial forearm blood flow. Kodama J; Katayama S; Tanaka K; Itabashi A; Kawazu S; Ishii J Diabetes Care; 1990 Nov; 13(11):1109-11. PubMed ID: 2261823 [TBL] [Abstract][Full Text] [Related]
20. Differential effects of captopril on regional haemodynamic responses to angiotensin I and bradykinin in conscious rats. Gardiner SM; Kemp PA; Bennett T Br J Pharmacol; 1993 Mar; 108(3):769-75. PubMed ID: 8467363 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]